Author(s): Foulkes WD, Smith IE, ReisFilho JS, Foulkes WD, Smith IE, ReisFilho JS
Abstract Share this page
Abstract Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment.
This article was published in N Engl J Med
and referenced in Journal of Cancer Science & Therapy